Company

Simplexia

Biotechnology Research Stockholm, Stockholms Län, Se 6 employees

Employees: 6
Contacts: 3
Emails: 3

simplexia.se LinkedIn

Simplexia Overview

Headquarters: Stockholm, Stockholms Län, Se
Website: simplexia.se
Industry: Biotechnology Research
Employees: 6
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

SandhanMatrimony.com

About Simplexia

Simplexia is develops vaccine against herpes simplex virus type (HSV-2) infection, which is the most common sexually transmitted infection in the world. The infection causes genital herpes with painful and recurrent genital blisters. HSV-2 can also cause life-threatening encephalitis and meningitis in newborns and immunocompromised patients. A major issue is that HSV-2 infected patients also suffer a three-fold increased risk of HIV acquisition.

Simplexia Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Simplexia Org Chart

Sample employees and titles

Name	Title	Location	Contact
Lena Degling Wikingsson	CEO at Dilafor Ab	Greater Stockholm Metropolitan Area, Sweden	Email
Nina Lindblom	Head Clinical and Business Development at Curovir Ab	Greater Stockholm Metropolitan Area, Sweden	Email
Jan Pilebjer	Chairman of the Board at Mivac Development Ab	Greater Gothenburg Metropolitan Area, Sweden	Email
Lindvi Gudmundsdotter, Phd	Proven Director: Leading Transformation, Drug Development, Deep Tech, Personalized Medicine, Innovation, Translational Medicine		View